HepaRegeniX Funding History

Since HepaRegeniX was founded in 2017, it has participated in 4 rounds of funding. In total HepaRegeniX has raised $62.3M. HepaRegeniX's last funding round was on Apr 2025 for a total of $24.4M.

HepaRegeniX Funding Rounds

Debt

Apr 2025

$24.4M

Wellington Partners

Series C

Jul 2024

$16.2M

Vesalius Biocapital IV, Novo Holdings, Boehringer Ingelheim Venture Fund, High-Tech Gründerfonds

Series B

Jan 2020

$12.2M

Boehringer Ingelheim Venture Fund GmbH, Novo Holdings A/S, High-Tech Grunderfonds Management GmbH, Coparion GmbH & Co. KG, Ascenion Gmbh

Series A

Jan 2017

$9.4M

Boehringer Ingelheim Venture Fund, Novo Seeds

HepaRegeniX Investors

Wellington Partners

Debt

Apr 2025

Vesalius Biocapital IV

Series C

Jul 2024

Novo Holdings

Series C

Jul 2024

Boehringer Ingelheim Venture Fund

Series C, Series A

Jul 2024, Jan 2017

High-Tech Gründerfonds

Series C

Jul 2024

HepaRegeniX has 11 investors, including Wellington Partners, Vesalius Biocapital IV and Novo Holdings. The latest investment occurred in Apr 2025.

HepaRegeniX Funding History

Since HepaRegeniX was founded in 2017, it has participated in 4 rounds of funding. In total HepaRegeniX has raised $62.3M. HepaRegeniX's last funding round was on Apr 2025 for a total of $24.4M.

HepaRegeniX Funding Rounds

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

Total Funding: $62.3M

HepaRegeniX Investors

INVESTOR

ROUND

FUNDING DATE

Total Investors: 11